VOLITIONRX LTD (VNRX) SEC Filings & Financial Intelligence
VOLITIONRX LTD (VNRX) is a publicly traded company on the NYSE, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VNRX
CIK: 93314
Exchange: NYSE
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Sadler, Gibb & Associates, LLC
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChad Sadler
Audit LocationDraper, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001477932-26-005936 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-28 | FORM 4 | 0001477932-26-005935 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-22 | FORM 8-K | 0001477932-26-005804 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-16 | — | SCHEDULE 13D/A Filing | 0001493152-26-042962 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-09 | FORM 8-K | 0001477932-26-005620 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-11 | FORM 8-K | 0001477932-26-005578 | View SEC Doc Filr Page |
| EFFECT | 2026-09-09 | — | EFFECT Filing | 9999999995-26-002936 | View SEC Doc Filr Page |
| S-3/A | 2026-09-09 | — | FORM S-3/A | 0001477932-26-005469 | View SEC Doc Filr Page |
| S-3/A | 2026-09-08 | — | FORM S-3/A | 0001477932-26-005458 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-04 | — | SCHEDULE 13D Filing | 0001493152-26-041611 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | FORM 8-K | 0001477932-26-005359 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-27 | FORM 8-K | 0001477932-26-005351 | View SEC Doc Filr Page |
| S-3 | 2026-08-28 | — | FORM S-3 | 0001477932-26-005317 | View SEC Doc Filr Page |
| 8-K | 2026-08-24 | 2026-08-19 | FORM 8-K | 0001477932-26-005251 | View SEC Doc Filr Page |
| S-8 | 2026-08-21 | — | FORM S-8 | 0001477932-26-005229 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493152-26-038374 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001477932-26-004995 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | FORM 8-K | 0001477932-26-004991 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-06 | FORM 8-K | 0001477932-26-004778 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-17 | FORM 8-K | 0001477932-26-004421 | View SEC Doc Filr Page |
| EFFECT | 2026-07-17 | — | EFFECT Filing | 9999999995-26-002355 | View SEC Doc Filr Page |
| S-3 | 2026-07-10 | — | FORM S-3 | 0001477932-26-004265 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | FORM 8-K | 0001477932-26-003932 | View SEC Doc Filr Page |
| 8-K | 2026-06-10 | 2026-06-07 | FORM 8-K | 0001477932-26-003740 | View SEC Doc Filr Page |
| 424B5 | 2026-06-09 | — | 424B5 | 0001477932-26-003713 | View SEC Doc Filr Page |